News
Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...
16h
MarketBeat on MSNSarepta Drops 42% on Fatalities; Markets Eye Solid BiosciencesIn another tragic incident, Sarepta Therapeutics (NASDAQ: SRPT) saw a second death in connection with its Duchenne muscular ...
Another patient has died from acute liver failure after receiving Sarepta’s gene therapy for DMD ; After a quiet start to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results